CytomX Therapeutics Eulerpool News

CytomX Therapeutics Notizie Azioni

CytomX Therapeutics è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie CytomX Therapeutics.

• 9 luglio ·

  Yahoo
  Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers
• 6 luglio ·

  Yahoo
  Do CytomX Therapeutics' (NASDAQ:CTMX) Earnings Warrant Your Attention?
• 29 maggio ·

  Yahoo
  CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
• 19 maggio ·

  Yahoo
  CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma
• 13 maggio ·

  SeekingAlpha
  CytomX Therapeutics: Doubling Overnight On Phase 1 Data... Still Bullish?
• 13 maggio ·

  Yahoo
  Q1 2025 CytomX Therapeutics Inc Earnings Call
• 12 maggio ·

  SeekingAlpha
  CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)
• 12 maggio ·

  SeekingAlpha
  CytomX Therapeutics, Inc. 2025 Q1 - Results - Earnings Call Presentation
• 28 aprile ·

  Yahoo
  CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting
• 10 aprile ·

  Yahoo
  VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study